Francesca Megiorni

Pubblicazioni

Titolo Pubblicato in Anno
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 2020
Epigenetics in rhabdomyosarcoma: cues to new biomarkers and targeted therapies EBIOMEDICINE 2020
BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells CANCER LETTERS 2020
Tlr4 t399i polymorphism and endometriosis in a cohort of italian women DIAGNOSTICS 2020
Differential DNA Methylation Encodes Proliferation and Senescence Programs in Human Adipose-Derived Mesenchymal Stem Cells FRONTIERS IN GENETICS 2020
Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization JOURNAL OF BIOMEDICAL SCIENCE 2020
Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma ONCOGENE 2019
Notch3 targeting. A novel weapon against ovarian cancer stem cells STEM CELLS INTERNATIONAL 2019
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2019
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation CANCER LETTERS 2019
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2019
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2019
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: insights from EVA study FRONTIERS IN ENDOCRINOLOGY 2019
Testosterone-mediates activation of androgenic signaling sustains in vitro the transformed and radioresistant phenotype of rhabdomysarcoma cell lines JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2018
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2018
Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2018
Synergistic effects of PARP inhibitors and ionizing radiation on growth and survival of rhabdomyosarcoma cells ANNALS OF ONCOLOGY 2018
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells CANCER LETTERS 2017
A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma ONCOLOGY REPORTS 2017
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells JOURNAL OF HEMATOLOGY & ONCOLOGY 2017

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma